| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |